VPP - State research programs in accordance with Section 35, Paragraph 1 of the Law on Scientific Activity of May 19, 2005 are a state order for conducting scientific research in a certain economic, educational, cultural or other state priority sector with the aim to promote the development of this sector.
Projects that are currently being implemented
Clinical, biochemical, immunogenetic paradigms of Covid-19 infection and their correlation with socio-demographic, etiological, pathogenetic, diagnostic, therapeutically and prognostically relevant factors to be included in the guidelines
The aim of the project is to identify socio-demographic, clinical, biochemical, molecular and immunological factors caused by SARS-CoV-2 infection, which affect susceptibility to the virus, the course and outcome of the disease, and to improve the effectiveness of diagnosis and treatment.
The project is funded by the VPP (National Research Program). Project no. VPP-COVID-2020 / 1-0023.
The duration of the project - 01/07/2020 until 31/12/2020 (prolonged till 31/03/2021)
Project identification no. - VPP-COVID-2020/1-0023
The total funding of the project - 497 580,00 EUR (including LU KPMI financing 49 980, 00 EUR)
The project is led by Riga Stradins University
LU KPMI responsibility - work package 8
More information - HERE
Program Nr. 5. - Biomedicine for Public Health (BIOMEDICINE) - The aim of the national research program "Biomedicine for public health" is to create world-wide knowledge and technologies for the survival and quality of life of the Latvian population in areas of the most threatening diseases - cardiovascular and metabolic diseases, oncological diseases, children and infectious diseases, as well as mental illnesses.
Project: No.4. - "Study of the possibility of reducing mortality caused by gastric cancer in conditions of Latvia"
Purpose of the project - Based on the analysis of the situation in Latvia, to develop a practical approach to public health and medical measures aimed at reducing the mortality caused by gastric cancer and the related negative effects of risk factors and pre-cancer condition.
Program Manager - Dr.med. Valdis Pīrāgs
Project Manager -Dr.med. Mārcis Leja
The duration of the study - 01/01/2017 - 31/12/2017